Clinical trial / 2015
Two-year calorie restriction reduced cardiometabolic risk factors and thyroid hormone in nonobese adults
In a 2-year trial, 218 nonobese adults aged 21-51 years were randomized to 25% caloric restriction or ad libitum diet. The restriction group achieved 11.7% calorie reduction and sustained 10.4% weight loss. Triiodothyronine decreased significantly more in the restricted group at 12 and 24 months (P<0.001), while weight-adjusted resting metabolic rate fell significantly more at 12 months (P=0.04) but not at 24 months. Core temperature was unchanged, and cardiometabolic risk factors decreased without harming quality of life.
- Study type
- Randomized controlled trial
- Who was studied
- 218 nonobese adults aged 21-51 years
- What was measured
- Resting metabolic rate, core temperature, triiodothyronine, and cardiometabolic risk factors
THE PAPER
A 2-Year Randomized Controlled Trial of Human Caloric Restriction: Feasibility and Effects on Predictors of Health Span and Longevity.
Ravussin E, Redman LM, Rochon J, Das SK, Fontana L, Kraus WE, Romashkan S, Williamson DA, Meydani SN, Villareal DT, Smith SR, Stein RI, Scott TM, Stewart TM, Saltzman E, Klein S, Bhapkar M, Martin CK, Gilhooly CH, Holloszy JO, Hadley EC, Roberts SB, CALERIE Study Group. J Gerontol A Biol Sci Med Sci, 2015.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.